Skip to main content
SpringerLink
Log in

Evidence-Based Strategies for the Optimization of Pharmacotherapy in Older People

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Geriatric pharmacotherapy represents one of the biggest achievements of modern medical interventions. However, geriatric pharmacotherapy is a complex process that encompasses not only drug prescribing but also age-appropriate drug development and manufacturing, appropriate drug testing in clinical trials, rational and safe prescribing, reliable administration and assessment of drug effects, including adherence measurement and age-appropriate outcomes monitoring. During this complex process, errors can occur at any stage, and intervention strategies to improve geriatric pharmacotherapy are targeted at improving the regulatory processes of drug testing, reducing inappropriate prescribing, preventing beneficial drug underuse and use of potentially harmful drugs, and preventing adverse drug interactions. The aim of this review is to provide an update on selected recent developments in geriatric pharmacotherapy, including age discrimination in drug trials, a new healthcare professional qualification and shared competence in geriatric drug therapy, the usefulness of information and communication technologies, and pharmacogenetics. We also review optimizing strategies aimed at medication adherence focusing on complex elderly patients.

Among the current information technologies, there is sufficient evidence that computerized decision-making support systems are modestly but significantly effective in reducing inappropriate prescribing and adverse drug events across healthcare settings. The majority of interventions target physicians, for whom the scientific concept of appropriate prescribing and the acceptability of the alert system used play crucial roles in the intervention’s success. For prescribing optimization, results of educational intervention strategies were inconsistent. The more promising strategies involved pharmacists or multidisciplinary teams including geriatric medicine services. However, methodological weaknesses including population and intervention heterogeneity do not allow for comprehensive meta-analyses to determine the clinical value of individual approaches.

In relation to drug adherence, a recent meta-analysis of 33 randomized clinical trials in older patients found behavioural interventions had significant effects, and these interventions were more effective than educational interventions. For patients with multiple conditions and polypharmacy, successful interventions included structured medication review, medication regimen simplification, administration aids and medication reminders, but no firm conclusion in favour of any particular intervention could be made. Interventions to optimize geriatric pharmacotherapy focused most commonly on pharmacological outcomes (drug appropriateness, adverse drug events, adherence), providing only limited information about clinical outcomes in terms of health status, morbidity, functionality and overall healthcare costs. Little attention was given to psychosocial and behavioural aspects of pharmacotherapy.

There is sufficient potential for improvements in geriatric pharmacotherapy in terms of drug safety and effectiveness. However, just as we require evidence-based, age-specific, pharmacological information for efficient clinical decision making, we need solid evidence for strategies that consistently improve the quality of pharmacological treatments at the health system level to shape ‘age-attuned’ health and drug policy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV

Similar content being viewed by others

References

  1. Stegemann S, Ecker F, Maio M, et al. Geriatric drug therapy: neglecting the inevitable majority. Ageing Res Rev 2010; 9: 384–98

    Article  PubMed  Google Scholar 

  2. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Final concept paper E7 (R1). Studies in support of special populations: geriatrics. 2008 [online]. Available from URL: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Q_As/E7R1_Final_Concept_Paper.pdf [Accessed 2012 Apr 17]

  3. O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging 2012; 29 (6): 437–52

    Article  PubMed  Google Scholar 

  4. Cherubini A, Corsonello A, Lattanzio F. Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging 2012; 29 (6): 463–75

    Article  PubMed  CAS  Google Scholar 

  5. Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging 2012; 29 (6): 453–62

    Article  PubMed  Google Scholar 

  6. Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging 2012; 29 (6): 495–510

    Article  PubMed  Google Scholar 

  7. Hanlon JT, Handler SM, Maher R, et al. Geriatric pharmacotherapy and polypharmacy. In: Fillit H, Rockwood K, Woodhouse K, editors. Brocklehurst’s textbook of geriatric medicine. 7th ed. London: Churchill Livingstone, 2010: 880–5

    Chapter  Google Scholar 

  8. Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010; 17: 571–84

    Article  PubMed  CAS  Google Scholar 

  9. Handler SM, Wright RM, Ruby CM, et al. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother 2006; 4: 264–72

    Article  PubMed  Google Scholar 

  10. van Spall HG, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007; 297: 1233–40

    Article  PubMed  Google Scholar 

  11. Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older subjects from ongoing clinical trials in heart failure. Arch Intern Med 2011; 171 (6): 550–6

    Article  PubMed  Google Scholar 

  12. Crome P, Lally F, Cherubini A, et al. Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study. Drugs Aging 2011; 28: 1–11

    Article  Google Scholar 

  13. PREDICT [online]. Available from URL: http://www.predicteu.org/index.html [Accessed 2012 Apr 12]

  14. Cherubini A, Del Signore S, Ouslander J, et al. Fighting against age discrimination in clinical trials. J Am Geriatr Soc 2010; 58 (9): 1791–6

    Article  PubMed  Google Scholar 

  15. Gemmill M. Research note: chronic disease management in Europe. London: The London School of Economics and Political Sciences, for the Commission, Directorate-General “Employment, Social Affairs and Equal Opportunities” Unit E1-Social and Demographic Analysis, 2008

  16. Saltvedt I, Spigset O, Ruths S, et al. Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. Eur J Clin Pharmacol 2005; 61 (12): 921–8

    Article  PubMed  Google Scholar 

  17. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116: 394–401

    Article  PubMed  Google Scholar 

  18. Busse R, Blümel M, Scheller-Kreinsen D, et al. Tackling chronic disease in Europe: strategies, interventions and challenges. Observatory Studies Series No. 20. Copenhagen: WHO Regional Office for Europe, on behalf of the European Observatory on Health Systems and Policies, 2010: 111

  19. Blum K. Nurse practitioners in Eastern Germany. Health Policy Monitor, 2006 Oct 8 [online]. Available from URL: http://www.hpm.org/survey/de/b8/3 [Accessed 2011 Aug 28]

  20. Bernabei R, Onder G, Landi F. Comprehensive care for older adults: case management approach. J Am Geriatr Soc 2010; 58 (6): 1202–3

    Article  PubMed  Google Scholar 

  21. Wehling M. Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: there are almost no guidelines for these patients. J Am Geriatr Soc 2011; 59 (2): 376–7

    Article  PubMed  Google Scholar 

  22. Van den Akker M, Buntinx F, Metsemakers JF, et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998; 51: 367–75

    Article  PubMed  Google Scholar 

  23. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716–24

    Article  PubMed  CAS  Google Scholar 

  24. Tinetti ME, Bogardus Jr ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870–4

    Article  PubMed  CAS  Google Scholar 

  25. Fusco D, Lattanzio F, Tosato M, et al. Development of CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project: rationale and methodology. Drugs Aging. 2009; 26 Suppl. 1: 3–13

    Article  PubMed  Google Scholar 

  26. Vogt-Ferrier N. Reviewing a complicated geriatric regimen. Eur Ger Med 2010; 1: 198–202

    Article  Google Scholar 

  27. Pilotto A, Panza F, Seripa D. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice. Curr Drug Metab 2011; 12: 621–34

    Article  PubMed  CAS  Google Scholar 

  28. Roden DM, Altman RB, Benowitz NL, et al., Pharmacogenetics Research Network. Pharmacogenomics: challenges and opportunities. Ann Intern Med 2006; 145 (10): 749–57

    Article  PubMed  Google Scholar 

  29. Pilotto A, Seripa D, Franceschi M, et al. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology 2007; 133 (2): 465–71

    Article  PubMed  CAS  Google Scholar 

  30. Higashi MK, Veenstra DL, Kondo LM, et al. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA 2002; 287 (13): 1690–8

    Article  PubMed  CAS  Google Scholar 

  31. Pilotto A, Franceschi M, D’Onofrio G, et al. Effect of a CYP2D6 polymorphism on the efficacy of donepezil in Alzheimer’s disease patients. Neurology 2009; 73 (10): 761–7

    Article  PubMed  CAS  Google Scholar 

  32. Savino M, Seripa D, Gallo AP, et al. Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs. Clin Lab 2011; 57: 887–93

    PubMed  CAS  Google Scholar 

  33. Klotz U. Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem. Int J Clin Pharmacol Ther 2006; 44 (7): 297–302

    PubMed  CAS  Google Scholar 

  34. Ulfvarson J, Rahmer PB, Fastbom J, et al. Medication reviews with computerized expert support: evaluation of a method to improve the quality of drug utilization in the elderly. Int J Health Care Qul Assur 2010; 23: 571–82

    Article  Google Scholar 

  35. Hayes TL, Cobbinah K, Dishongh T, et al. A study of medication-taking and unobtrusive, intelligent reminding. Telemed J E Health 2009; 15 (8): 770–6

    Article  PubMed  Google Scholar 

  36. Handler SM, Hanlon JT. Detecting adverse drug events using nursing home specific trigger tool. Ann Longterm Care 2010; 18 (5): 17–22

    PubMed  Google Scholar 

  37. Hornick TR, Higgins PA, Stollings C, et al. Initial evaluation of a computer-based medication management tool in a geriatric clinic. Am J Geriatr Pharmacother 2006; 4: 62–9

    Article  PubMed  Google Scholar 

  38. Yourman L, Concato J, Agostini JV. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review. Am J Geriatr Pharmacother 2008; 6: 119–29

    Article  PubMed  Google Scholar 

  39. Gurwitz JH, Field TS, Rochon P, et al. Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc 2008; 56 (12): 2225–33

    Article  PubMed  Google Scholar 

  40. Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ 2003; 169: 549–56

    PubMed  Google Scholar 

  41. Terrell KM, Perkins AJ, Dexter PR, et al. Computerized decision support to reduce potentially inappropriate prescribing to older emergency department patients: a randomized, controlled trial. J Am Geriatr Soc 2009; 57: 1388–94

    Article  PubMed  Google Scholar 

  42. Mattison ML, Afonso KA, Ngo LH, et al. Preventing potentially inappropriate medication use in hospitalized older patients with a computerized provider order entry warning system. Arch Intern Med 2010; 170: 1331–6

    Article  PubMed  Google Scholar 

  43. Raebel MA, Charles J, Dugan J, et al. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc 2007; 55 (7): 977–85

    Article  PubMed  Google Scholar 

  44. van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006; 130: 138–47

    Article  Google Scholar 

  45. Avorn J. Medication use in older patients: better policy could encourage better practice. JAMA 2010; 304 (14): 1606–7

    Article  PubMed  CAS  Google Scholar 

  46. Jansen PA. Specific needs for research in geriatrics [presentation]. Expertisecentre Pharmacotherapy in Old Persons (EPHOR), 2011 [online]. Available from URL: http://ephor.artsennet.nl/English-website.htm [Accessed 2011 Aug 28]

  47. Scott-Cawiezell J, Madsen RW, Pepper GA, et al. Medication safety teams’ guided implementation of electronic medication administration records in five nursing homes. Jt Comm J Qual Patient Saf 2009; 35: 29–35

    PubMed  Google Scholar 

  48. Spinewine A, Schmader K, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370: 73–84

    Article  Google Scholar 

  49. Kaur S, Mitchell G, Vitetta L, et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 2009; 26 (12): 1013–28

    Article  PubMed  Google Scholar 

  50. Steinman MA, Hanlon JT. Managing medications in clinically complex elders. JAMA 2010; 304 (14): 1592–601

    Article  PubMed  CAS  Google Scholar 

  51. Marcum ZA, Handler SV, Wright R, et al. Interventions to improve suboptimal prescribing in nursing homes: a narrative review. Am J Geriatr Pharmacother 2010; 8 (3): 183–200

    Article  PubMed  Google Scholar 

  52. Loganathan M, Singh S, Franklin BD, et al. Interventions to optimize prescribing in care homes: systematic review. Age Ageing 2011; 40: 150–62

    Article  PubMed  Google Scholar 

  53. Trivalle C, Cartier T, Verny C, et al., for the IMEPAG GROUP. Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects. J Nutr Health Aging 2010; 14: 57–61

    Article  PubMed  CAS  Google Scholar 

  54. Crotty M, Halbert J, Rowett D, et al. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004; 33: 612–7

    Article  PubMed  Google Scholar 

  55. Strandberg TE, Pitkala KH, Berglind S, et al. Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study. A randomised controlled trial. Am Heart J 2006; 152: 585–92

    Article  PubMed  Google Scholar 

  56. Tulner LR, van Campen JP, Frankfort SV, et al. Changes in under-treatment after comprehensive geriatric assessment: an observational study. Drugs Aging 2010; 27: 831–43

    Article  PubMed  Google Scholar 

  57. Lampela P, Hartikainen S, Lavikainen P, et al. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. Drugs Aging 2010; 27: 507–21

    Article  PubMed  Google Scholar 

  58. Lutters M, Harbarth S, Janssens JP, et al. Impact of a comprehensive, multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J Am Geriatr Soc 2004; 52: 112–6

    Article  PubMed  Google Scholar 

  59. Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging 2004; 21 (12): 793–811

    Article  PubMed  Google Scholar 

  60. World Health Organization (WHO). Adherence to long- term therapies: evidence for action. Geneva: WHO, 2003 [online]. Available from URL: http://whqlibdoc.who.int/publications/2003/9241545992.pdf [Accessed 2011 Aug 28]

    Google Scholar 

  61. Cooper C, Carpenter I, Katona C, et al. The AdHOC Study of older adults’ adherence to medication in 11 countries. Am J Geriatr Psychiatry 2005; 13 (12): 1067–76

    PubMed  Google Scholar 

  62. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011; 9: 11–23

    Article  PubMed  Google Scholar 

  63. Conn VS, Hafdahl AR, Cooper PS, et al. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist 2009; 49 (4): 447–62

    Article  PubMed  Google Scholar 

  64. Haynes R, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; (4): CD000011

    Google Scholar 

  65. Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med 2001; 77: 703–7

    Article  CAS  Google Scholar 

  66. Topinkova E, Fialova D, Carpenter GI, et al. Cross-national comparison of drug compliance and non-compliance associated factors in the elderly with polypharmacotherapy. Cas Lek Cesk 2006; 145 (9): 726–32

    PubMed  CAS  Google Scholar 

  67. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 2008; 31: 213–24

    Article  PubMed  Google Scholar 

  68. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med 2007; 22: 864–71

    Article  PubMed  Google Scholar 

  69. Doggrell SA. Adherence to medicines in the older-aged with chronic conditions. Drugs Aging 2010; 27 (3): 239–54

    Article  PubMed  Google Scholar 

  70. George J, Elliot RA, Stewart DC. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging 2008; 25 (4): 307–24

    Article  PubMed  Google Scholar 

  71. Williams A, Manias E, Walker R. Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs 2008; 63 (2): 132–43

    Article  PubMed  Google Scholar 

  72. Hawe P, Higgins G. Can medication education improve the drug compliance of the elderly? Evaluation of an inhospital program. Patient Educ Couns 1990; 16: 151–60

    Article  PubMed  CAS  Google Scholar 

  73. Hanlon JT, Weinberger M, Samsa GP, et al. A randomised, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100: 428–37

    Article  PubMed  CAS  Google Scholar 

  74. Bernsten C, Bjorkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 2001; 18 (1): 63–77

    Article  PubMed  CAS  Google Scholar 

  75. Grymonpre RE, Williamson DA, Montgomery PR. Impact of a pharmaceutical care model for non-institutionalised elderly: results of a randomised controlled trial. Int J Pharm Prac 2001; 9: 235–41

    Article  Google Scholar 

  76. Nazareth I, Burton A, Shulman S, et al. A pharmacy discharge plan for hospitalized elderly patients — a randomized controlled trial. Age Ageing 2001; 30 (1): 33–40

    Article  PubMed  CAS  Google Scholar 

  77. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care programme on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. J Am Med Assoc 2006; 296 (21): 2563–71

    Article  CAS  Google Scholar 

  78. Sturgess IK, McElnay JC, Hughes CM, et al. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 2003; 25 (5): 218–26

    Article  PubMed  Google Scholar 

  79. Volume CI, Farris KB, Kassam R, et al. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc (Wash) 2001; 41: 411–20

    CAS  Google Scholar 

  80. Wu JYF, Leung WY, Chang S, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. Br Med J 2006; 333 (7567): 522–7

    Article  Google Scholar 

  81. Hayes TL, Larimer N, Adami A, et al. Medication adherence in healthy elders: Small cognitive changes make a big difference. J Aging Health 2009; 21: 567–80

    Article  PubMed  Google Scholar 

  82. Insel K, Morrow D, Brewer B, et al. Executive function, working memory, and medication adherence among older adults. J Gerontol 2006; 61: P102–7

    Article  Google Scholar 

  83. Arlt S, Lindner R, Rösler A, et al. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging 2008; 25 (12): 1033–47

    Article  PubMed  Google Scholar 

  84. Applegate WB, Blass JP, Williams TF. Instruments for functional assessment of older patients. N Engl J Med 1990; 322: 1207–14

    Article  PubMed  CAS  Google Scholar 

  85. Elliott RA, Marriott JL. Standardized assessment of patients’ capacity to manage medications: a systematic review of published instruments. BMC Geriatr 2009; 9: 27. doi: 10.1186/1471-2318-9–27

    Article  PubMed  Google Scholar 

  86. Farris KB, Phillips BB. Instruments assessing capacity to manage medications. Ann Pharmacother 2008; 42: 1026–36

    Article  PubMed  Google Scholar 

  87. Edelberg HK, Shallenberger E, Wei JY. Medication management capacity in highly functioning community-living older adults: detection of early deficits. J Am Geriatr Soc 1999; 47: 592–6

    PubMed  CAS  Google Scholar 

  88. Orwig D, Brandt N, Gruber-Baldini AL. Medication management assessment for older adults in the community. Gerontologist 2006; 46: 661–8

    Article  PubMed  Google Scholar 

  89. Patterson TL, Lacro J, McKibbin CL, et al. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia. J Clin Psychopharmacol 2002; 22: 11–9

    Article  PubMed  Google Scholar 

  90. Schmidt KS, Lieto JM. Validity of the Medication Administration Test among older adults with and without dementia. Am J Geriatr Pharmacother 2005; 3: 255–61

    Article  PubMed  Google Scholar 

  91. Tran T, Elliott RA, Taylor SE, et al. A self-administration of medications program to identify and address potential barriers to adherence in elderly patients. Ann Pharmacother. Epub 2011 Jan 12

  92. Lam P, Elliot RA, George J. Impact of a self-administration of medications programme on elderly inpatients’ competence to manage medications: a pilot study. J Clin Pharm Ther 2011; 36 (1): 80–6

    Article  PubMed  CAS  Google Scholar 

  93. Huisman-Baron M, van der Veen L, Jansen PA, et al. Criteria for drug selection in frail elderly persons. Drugs Aging 2011; 28 (5): 391–402

    Article  PubMed  Google Scholar 

  94. Nolte E, McKee M. Integration and chronic care: a review. In: Nolte E, McKee M, editors. Caring for people with chronic conditions: a health system perspective. Maidenhead: Open University Press, 2008: 64–91

    Google Scholar 

  95. O’Neil D. Dialogue at Davos for and aging world. J Am Geriatr Soc 2011; 59: 1540–1

    Article  Google Scholar 

  96. Patterson SM, Hughes CM, Lapane K. Assessment of a United States pharmaceutical care model for nursing homes in the United Kingdom. Pharm World Sci 2007; 29: 517–25

    Article  PubMed  Google Scholar 

  97. European Commission. i2010 — A European information society for growth and employment. Brussels: European Commission, 2009 [online]. Available from URL: http://ec.europa.eu/information_society/eeurope/i2010/index_en.htm [Accessed 2011 Aug 28]

Download references

Acknowledgements

The paper was prepared by the authors without any financial support. The research work of Professor Topinková was partly supported by grant No. NT-10-029-4/2008 IGA Ministry of Health, Czech Republic.

Author information

Authors and Affiliations

  1. Department of Geriatric Medicine, First Faculty of Medicine, Charles University in Prague, Londynska 15, 120 00, Prague 2, Czech Republic

    Eva Topinková MD, PhD

  2. Luxembourg University, Luxembourg City, Luxembourg

    Jean Pierre Baeyens

  3. Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva Medical School and University Hospitals, Geneva, Switzerland

    Jean-Pierre Michel & Pierre-Olivier Lang

Authors
  1. Eva Topinková MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean Pierre Baeyens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Pierre Michel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pierre-Olivier Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eva Topinková MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Topinková, E., Baeyens, J.P., Michel, JP. et al. Evidence-Based Strategies for the Optimization of Pharmacotherapy in Older People. Drugs Aging 29, 477–494 (2012). https://doi.org/10.2165/11632400-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11632400-000000000-00000

Keywords

Search

Navigation